MEDNA launching Quantitative Binding Antibody Test for SARS-CoV-2

2020-06-16

Based in Irving Texas, MEDNA launched a Quantitative Binding Antibody Test for SARS-2CoV-2.  This test detects the presence or absence of antibodies to SARS-CoV-2, the virus that causes COVID-19.  MEDNA's quantitative binding test detects IgG antibody content in blood samples.  It provides a quantitative readout instead of positive or negative result reporting.  This test is an important tool in the fight against COVID-19 in the coming months as people wish to know if they've been exposed.


Test Highlights

• Antigen is the full-length trimeric spike protein of SARS-CoV-2 virus

• Quantitative readout instead of positive or negative reading

• Works with venous blood collection as well as finger prick


Visit https://dx.medna.us/ for more information.